Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-national, Multi-center, Randomized Controlled Trial to Evaluate the Clinical Utility of Non-invasive Endometrial Receptivity Test (Ora) in Patients With Implantation Failure

NCT06544837 is registered in ClinicalTrials.gov with Inti Labs as lead sponsor.

NCT NCT06544837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06544837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-national, Multi-center, Randomized Controlled Trial to Evaluate the Clinical Utility of Non-invasive Endometrial Receptivity Test (Ora) in Patients With Implantation Failure
Lead sponsor
Inti Labs
Phase
Not applicable
Overall status
Recruiting
Start date
June 22, 2024
Completion date
June 1, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial receptivity, implantation, ivf, microrna, non-invasive testing, window of implantation